Skip to main content

Advertisement

Table 2 Median and distribution of infliximab serum trough levels

From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

  Prior to infusion 1 hour after infusion 50% of the infusioncycle 75% of the infusioncycle 100% of the infusioncycle
Median infliximab levels
Median infliximab levels (p25-p75) 0.6 (0.0 - 3.1) 77.0 (65-89) 5.9 (1.5-13) 2.7 (0.2-5.7) 0.0 (0.0-3.1).